Lantern Pharma (LTRN)

• Market cap: $45.9M
• 1 day: 8.76%
• 5 days: 14.65%
• 1 month: 60.71%
• 3 months: 34.33%
• 6 months: -0.55%
• Year to date: 15.76%
• 1 year: 25.44%
• 5 years: -76.19%
• 10 years: -75.92%
• Sector: Healthcare
• Industry: Biotechnology

About: Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Employees: 16